工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A Flow Cytometry-Based Method for Assessing CAR Cell Binding Kinetics Using Stable CAR Jurkat Cells.
A Flow Cytometry-Based Method for Assessing CAR Cell Binding Kinetics Using Stable CAR Jurkat Cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)是可重编程免疫细胞以识别特定抗原的合成融合蛋白。CAR-T 已用于血液癌症,但决定其反应的机制和结构特性尚未完全明了。本研究提出一种使用常规流式细胞仪测定细胞亲合力的简便方法,可评估CAR-T 与抗原阳性靶细胞的相互作用动力学。研究将稳定表达CAR的Jurkat细胞与抗原阳性或阴性靶细胞按不同效靶比例短时共培养,通过CAR-靶细胞双联体形成作为主动结合的读数。优化方案后,不同抗原结合结构域的CAR呈现独特结合曲线;结合动力学稳定、依赖靶抗原表达并需要主动生物信号。虽然目前尚不清楚结合强弱哪种更有利于疗效,该简化方法有助于理解调节CAR功能的近端信号事件。该实验可适用于多类血液及实体瘤靶点,在标准流式细胞仪上无需染色、两小时内即可完成。
Chimeric antigen receptors (CARs) are synthetic fusion proteins that can reprogram immune cells to target specific antigens. CAR-expressing T cells have emerged as an effective treatment method for hematological cancers; despite this success, the mechanisms and structural properties that govern CAR responses are not fully understood.
Here, we provide a simple assay to assess cellular avidity using a standard flow cytometer. This assay measures the interaction kinetics of CAR-expressing T cells and targets antigen-expressing target cells. By co-culturing stably transfected CAR Jurkat cells with target positive and negative cells for short periods of time in a varying effector-target gradient, we were able to observe the formation of CAR-target cell doublets, providing a readout of actively bound cells. When using the optimized protocol reported here, we observed unique cellular binding curves that varied between CAR constructs with differing antigen binding domains. The cellular binding kinetics of unique CARs remained consistent, were dependent on specific target antigen expression, and required active biological signaling.
While existing literature is not clear at this time whether higher or lower CAR cell binding is beneficial to CAR therapeutic activity, the application of this simplified protocol for assessing CAR binding could lead to a better understanding of the proximal signaling events that regulate CAR functionality. Key features Determines CAR receptor cellular interaction kinetics using a Jurkat cell model.
Can be used for a wide variety of CAR target antigens, including both hematological and solid tumor targets. Experiments can be performed in under two hours with no staining using a standard flow cytometer. Requires stable CAR Jurkat cells and target cells with stable fluorescent marker expression for optimal results.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。